Mesenteric lymphadenitis in children
Conditions
Interventions
Bifidobacterium group :Bifidobacterium group: on the basis of symptomatic treatment in the control group, oral Bifidobacterium tetragenous viable bacteria tablets were given .
The subjects did not tak
control group:The control group was given symptomatic treatment according to the condition.
The subjects did not take yogurt and other foods that could affect the study results during the treatment.
Sponsors
Chengdu BOE Hospital
Eligibility
Sex/Gender
All
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. In accordance with the clinical diagnostic criteria of ML; 2.The age ranged from 3 to 14 years; 3. Good treatment compliance, cooperation with examination and follow-up; 4. Informed consent was signed by parents of children.
Exclusion criteria
Exclusion criteria: 1. Use of antibiotics, microecological agents, and other drugs affecting the gut microbiota within the past 2 weeks. 2. Allergic constitutions, especially those with previous allergies to probiotic components such as Bifidobacterium infantis, Lactobacillus acidophilus, Enterococcus faecalis, and Bacillus cereus. 3.Abdominal pain caused by other digestive system diseases, appendicitis and other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intestinal flora; | — |
Secondary
| Measure | Time frame |
|---|---|
| The degree and duration of abdominal pain relief; | — |
Countries
China
Contacts
Public ContactGuan Minli
Chengdu BOE Hospital
Outcome results
None listed